nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant and neoadjuvant treatment of melanoma
|
Koelblinger, Peter |
|
|
13 |
3 |
p. 301-305 |
artikel |
2 |
ASH highlights 2019: “aggressive B-cell lymphoma”
|
Schmitt, Clemens A. |
|
|
13 |
3 |
p. 266-269 |
artikel |
3 |
Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors
|
Tanaka, Osamu |
|
|
13 |
3 |
p. 353-356 |
artikel |
4 |
Chemoradiotherapy alone or chemoradiotherapy followed by surgery in rectal cancer
|
Lunger, Fabian |
|
|
13 |
3 |
p. 324-328 |
artikel |
5 |
Circulating tumour DNA-guided adjuvant chemotherapy in colorectal carcinoma
|
Reichinger, Andreas |
|
|
13 |
3 |
p. 334-336 |
artikel |
6 |
Comparison of outcomes of two non-BCNU-containing conditioning regimens used in autologous stem cell transplantation for relapsed/refractory lymphoma
|
El-Ghammaz, Amro Mohamed Sedky |
|
|
13 |
3 |
p. 294-300 |
artikel |
7 |
Creating the “new normal” post-Coronavirus world—web-communication replacing face-to-face interaction
|
Hilbe, Wolfgang |
|
|
13 |
3 |
p. 245-246 |
artikel |
8 |
Fine-tuning front-line therapy in chronic lymphocytic leukemia
|
Bohn, Jan-Paul |
|
|
13 |
3 |
p. 259-265 |
artikel |
9 |
Four lines of immunochemotherapy combinations in a young patient with an aggressive metastatic colorectal cancer
|
Witte, Frédéric H. |
|
|
13 |
3 |
p. 337-340 |
artikel |
10 |
Highlights of ASH 2019—multiple myeloma
|
Ludwig, Heinz |
|
|
13 |
3 |
p. 270-275 |
artikel |
11 |
Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?
|
Beslija, Semir |
|
|
13 |
3 |
p. 255-256 |
artikel |
12 |
memo—publisher’s report 2019
|
Sillaber, Alois |
|
|
13 |
3 |
p. 257-258 |
artikel |
13 |
Myeloid diseases—Chronic Myeloid Leukemia (CML)—report from ASH 2019 on new developments
|
Petzer, Andreas L. |
|
|
13 |
3 |
p. 276-279 |
artikel |
14 |
Neoadjuvant chemoradiotherapy in rectal cancer
|
Arnold, Christoph Reinhold |
|
|
13 |
3 |
p. 329-333 |
artikel |
15 |
News from ASH 2019
|
Gunsilius, Eberhard |
|
|
13 |
3 |
p. 247-248 |
artikel |
16 |
New systemic treatment options in mycosis fungoides and Sézary syndrome
|
Seidl-Philipp, Magdalena |
|
|
13 |
3 |
p. 280-284 |
artikel |
17 |
Patient-reported outcomes and psycho-oncological screening in hematology: a practical example of routine electronic monitoring
|
Lehmann, Jens |
|
|
13 |
3 |
p. 285-293 |
artikel |
18 |
Rectal cancer among younger Egyptian patients—clinico-pathological features and oncologic outcomes: A single institution experience
|
Zaid, Amir M. |
|
|
13 |
3 |
p. 314-323 |
artikel |
19 |
Rectal cancer: latest developments and innovative new treatment concepts
|
Amann, Arno |
|
|
13 |
3 |
p. 251-252 |
artikel |
20 |
San Antonio Breast Cancer Symposium 2019: human epidermal growth factor receptor 2(HER2)-positive breast cancer and image-guided biopsy to detect pathologic complete response (pCR)
|
Dormann, Clemens |
|
|
13 |
3 |
p. 341-345 |
artikel |
21 |
San Antonio 2019: interesting topics for daily clinical practice in breast cancer
|
Galid, Arik |
|
|
13 |
3 |
p. 349-352 |
artikel |
22 |
The future of combination therapies in advanced melanoma
|
Hoeller, Christoph |
|
|
13 |
3 |
p. 309-313 |
artikel |
23 |
Therapies in flux: highlights of the 2019 San Antonio Breast Cancer Symposium (SABCS)
|
Gampenrieder, Simon Peter |
|
|
13 |
3 |
p. 253-254 |
artikel |
24 |
The therapeutic landscape of advanced melanoma
|
Richtig, Erika |
|
|
13 |
3 |
p. 306-308 |
artikel |
25 |
Treatment of advanced melanoma
|
Nguyen, Van Anh |
|
|
13 |
3 |
p. 249-250 |
artikel |
26 |
Treatment options in early triple-negative breast cancer
|
Suppan, Christoph |
|
|
13 |
3 |
p. 346-348 |
artikel |